With a keen interest in new opportunities combined with a solid financial position, Zila seeks to further expand its oral disease detection and treatment portfolio into new markets. Zila has already completed several company, product, and technology acquisitions, and expects to continue its robust business development program as an important element of its overall growth strategy.

We are committed to continued growth and are interested in learning about prospective opportunities in the specialty pharmaceutical market. Please direct your inquiries regarding business or product collaboration opportunities to:

By Facsimile: 602-234-2318

By Regular Mail:
Zila, Inc.
Business Development
5227 N 7th Street
Phoenix, AZ 85014